Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by Forsta AP Fonden

Forsta AP Fonden raised its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 83.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 385,600 shares of the pharmacy operator’s stock after acquiring an additional 175,400 shares during the quarter. Forsta AP Fonden’s holdings in Walgreens Boots Alliance were worth $3,455,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in WBA. New Covenant Trust Company N.A. purchased a new position in shares of Walgreens Boots Alliance during the 1st quarter worth approximately $35,000. Iron Horse Wealth Management LLC grew its holdings in Walgreens Boots Alliance by 162.5% during the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 1,300 shares during the last quarter. FinTrust Capital Advisors LLC grew its holdings in Walgreens Boots Alliance by 60.4% during the 1st quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock valued at $46,000 after buying an additional 802 shares during the last quarter. Blue Trust Inc. raised its holdings in shares of Walgreens Boots Alliance by 87.0% in the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 1,081 shares during the last quarter. Finally, Continuum Advisory LLC lifted its position in shares of Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 1,020 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

WBA stock opened at $9.35 on Wednesday. The company has a market cap of $8.08 billion, a PE ratio of -0.93, a price-to-earnings-growth ratio of 1.20 and a beta of 0.70. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67. The stock has a 50-day moving average price of $9.26 and a two-hundred day moving average price of $12.61. Walgreens Boots Alliance, Inc. has a 12-month low of $8.22 and a 12-month high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. The business had revenue of $37.50 billion during the quarter, compared to analysts’ expectations of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.67 EPS. As a group, research analysts predict that Walgreens Boots Alliance, Inc. will post 1.54 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 10.70%. The ex-dividend date is Monday, November 18th. Walgreens Boots Alliance’s payout ratio is currently -9.99%.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Truist Financial dropped their price objective on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research report on Monday, October 7th. Barclays boosted their price objective on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 16th. Morgan Stanley decreased their target price on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research report on Friday, October 11th. JPMorgan Chase & Co. cut their price target on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a report on Friday, August 30th. Finally, Jefferies Financial Group decreased their price objective on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday, October 23rd. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and a consensus target price of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.